April 21, 2021
Defining and processing protocol deviations (PD) can be complex and varied, and present challenges for several stakeholders within the clinical trial ecosystem. Improvements in protocol deviation management, and reporting processes can aid those conducting clinical research in a variety of ways including: rapid identification of important protocol deviations and assessing potential or real impact of…
Explore
December 9, 2020
In early February, TransCelerate had a highly engaging Annual Meeting with FDA colleagues to discuss our 2020 plans and look for promising ways to accelerate and evolve new areas of clinical research. By early March, the entire world—our industry included—went into shock as COVID-19 travelled the globe, hitting humanity in extraordinary ways. 2020 has impacted…
Explore
July 28, 2020
Like many features of our personal and professional lives, the COVID-19 pandemic has had a significant impact on clinical research, especially on active treatment studies. From increased difficulty enrolling participants in studies and collecting measurements to reduced availability of supplies and potential new biases in the data, clinical research is grappling with major changes and…
Explore
